In March 2025, the company introduced new ideas for any direct-to-purchaser giving of its Wegovy weight loss drug. The company recognized a completely new pharmacy, termed NovoCare, which might demand clients $499 a month for access to the drug, below fifty percent the price of the drug by means of other pharmaceutical distribution networks.[53]Res